Advanced Melanoma Skin Cancer Survival Rate Jumps from 1% to 40%

For patients with a deadly skin cancer who previously had few treatment options, a drug that will boost their immune systems has shown great promise.

After 655 patients with advanced melanoma received the drug pembrolizumab, a new study showed 15% of people in the trial had no sign of cancer three years later, achieving total remission.…